Postdoctoral Fellow - Cancer Epigenetics and RNA Therapeutics jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 1 month ago

Postdoctoral Fellow - Cancer Epigenetics and RNA Therapeutics

City of Hope is at the forefront of groundbreaking research, focusing on innovative approaches to combat cancer and other life-threatening illnesses. The postdoctoral fellow will work in Dr. Xiaolan Deng's laboratory, engaging in research related to RNA Biology, Cancer Biology, and Epigenetics, among other areas, to uncover novel genetic regulations and their mechanisms.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Work with a range of techniques, including but not limited to: Flow cytometry, mass spectrometry/quantitative phospho-profiling, CyTOF, mouse genetics models, xenograft assays, retroviral gene delivery, chemical biology, drug development, whole exome sequencing and RNA-seq-analysis of clonal evolution of cancer, dot blots, RNA modification-seq, ChIP-seq, RIP-seq, PAR-CLIP-seq, and pre-clinical drug testing in xenotransplantation models, etc

Qualification

RNA biologyRNA modifications/editingEpitranscriptomicsDrug discoveryBiochemistryMouse geneticsStructural biologyImmunologyTeamworkCommunication skills

Required

A Ph.D. and/or M.D. degree(s)
A solid background in RNA biology, RNA modifications/editing, epitranscriptomics, chromatin remodeling, mRNA-based therapeutics, drug discovery, drug delivery, biochemistry, chemical biology, development, epigenetics, immunology, tumor immunity, tumor microenvironment, pathology, metabolism, structural biology, and/or stem cell research
Mouse model research experience is a plus
Highly motivated individuals with the ability to work in a team environment
Good oral and written communication skills in English

Benefits

Comprehensive Benefits

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase